Role of microenvironment on neuroblastoma SK-N-AS SDHB-silenced cell metabolism and function

Endocrine-Related Cancer

Volumn 22, Issue 3, 2015, Pages 409-417

  Rapizzi, Elena ^a   Fucci, Rossella ^a   Giannoni, Elisa ^a   Canu, Letizia ^a   Richter, Susan ^b   Cirri, Paolo ^a   Mannelli, Massimo ^a,c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c ISTITUTO TOSCANO TUMORI   (Italy)

Author keywords

Fibroblast; Glucose lactate; Pheochromocytoma paraganglioma; SDHB; Tumor microenvironment

Indexed keywords

GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; LACTIC ACID; METALLOPROTEINASE; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE B; UNCLASSIFIED DRUG; SDHD PROTEIN, HUMAN;

ARTICLE; CELL FUNCTION; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; IN VIVO STUDY; NEURAL CREST; NEUROBLASTOMA; NEUROBLASTOMA CELL LINE; PHENOTYPE; PRIMARY CULTURE; PROTEIN DEPLETION; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT; ADRENAL TUMOR; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; METABOLISM; PARAGANGLIOMA; PATHOLOGY; PHEOCHROMOCYTOMA; PHYSIOLOGY; TUMOR CELL LINE;

ADRENAL GLAND NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; NEUROBLASTOMA; PARAGANGLIOMA; PHEOCHROMOCYTOMA; SUCCINATE DEHYDROGENASE; TRANSFECTION; TUMOR MICROENVIRONMENT;

EID: 84937039434     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-14-0479     Document Type: Article

References (40)

1. Adam J, Yang M, Soga T & Pollard PJ 2013 Rare insights into cancer biology. Oncogene 33 2547-2556. (doi:10.1038/onc.2013.222)
2. Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, Van Der Mey A, Taschner PE, Rubinstein WS, Myers EN et al. 2000 Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287848-851. (doi:10.1126/science.287.5454.848)
3. Castro-Vega LJ, Buffet A, De Cubas AA, Cascón A, Menara M, Khalifa E, Amar L, Azriel S, Bourdeau I, Chabre O et al. 2014 Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas. Human Molecular Genetics 23 2440-2446. (doi:10.1093/hmg/ddt639)
4. Dahia PL 2014 Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nature Reviews Cancer 14 108-119. (doi:10.1038/nrc3648)
5. Dahia PL, Ross KN, Wright ME, Hayashida CY, Santagata S, Barontini M, Kung AL, Sanso G, Powers JF, Tischler AS et al. 2005 A HIF1a regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genetics 1 72-80. (doi:10.1371/journal.pgen.0010008)
6. Eng C, Kiuru M, Fernandez MJ & Aaltonen LA 2003 A role for mitochondrial enzymes in inherited neoplasia and beyond. Nature Reviews Cancer 3 193-202. (doi:10.1038/nrc1013)
7. Favier J, Brière JJ, Burnichon N, Rivière J, Vescovo L, Benit P, Giscos-Douriez I, De Reyniès A, Bertherat J, Badoual C et al. 2009 The Warburg effect is genetically determined in inherited pheochromocytomas. PLoS ONE 4 e7094. (doi:10.1371/journal.pone.0007094)
8. Fiaschi T, Marini A, Giannoni E, Taddei ML, Gandellini P, De Donatis A, Lanciotti M, Serni S, Cirri P & Chiarugi P 2012 Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay. Cancer Research 72 5130-5140. (doi:10.1158/0008-5472.CAN-12-1949)
9. Ghayee HK, Bhagwandin VJ, Stastny V, Click A, Ding LH, Mizrachi D, Zou YS, Chari R, Lam WL, Bachoo RM et al. 2013 Progenitor cell line (hPheo1) derived from a human pheochromocytoma tumor. PLoS ONE 8 e65624. (doi:10.1371/journal.pone.0065624)
10. Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Crespin M, Nau V, Khau Van Kien P, Corvol P, Plouin PF, Jeunemaitre X et al. 2003 Mutations in the SDHB gene are associated with extra-adrenal and/or malignant pheochromocytomas. Cancer Research 63 5615-5621.
11. Goffrini P, Ercolino T, Panizza E, GiachèV, Cavone L, Chiarugi A, Dima V, Ferrero I & Mannelli M 2009 Functional study in a yeast model of a novel succinate-dehydrogenase subunit B gene germline missense mutation (C191Y) diagnosed in a patient affected by a glomus tumor. Human Molecular Genetics 18 1860-1868. (doi:10.1093/hmg/ddp102)
12. Greene LA & Tischler AS 1976 Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. PNAS 73 2424-2428. (doi:10.1073/pnas.73.7.2424)
13. Hanahan D& Coussens LM2012 Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21 309-322. (doi:10.1016/j.ccr.2012.02.022)
14. Hanahan D & Weinberg RA 2011 Hallmarks of cancer: the next generation. Cell 144 646-674. (doi:10.1016/j.cell.2011.02.013)
15. Hu M & Polyak K 2008 Microenvironmental regulation of cancer development. Current Opinion in Genetics & Development 18 27-34. (doi:10.1016/j.gde.2007.12.006)
16. Jochmanová I, Zelinka T, Widimský J Jr & Pacak K 2014 HIF signaling pathway in pheochromocytoma and other neuroendocrine tumors. Physiological Research 63 (Suppl 2) S251-S262.
17. Kaelin WG Jr & McKnight SL 2013 Influence of metabolism on epigenetics and disease. Cell 153 56-69. (doi:10.1016/j.cell.2013.03.004)
18. Karagiannis GS, Poutahidis T, Erdman SE, Kirsch R, Riddell RH & Diamandis EP 2012 Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue. Molecular Cancer Research 10 1403-1418. (doi:10.1158/1541-7786.MCR-12-0307)
19. Klemm F & Joyce JA 2014 Microenvironment regulation of therapeutic response in cancer. Trends in Cell Biology 25 198-213. (doi:10.1016/j.tcb.2014.11.006)
20. Koivunen P, Hirsilä M, Remes AM, Hassinen IE, Kivirikko KI & Myllyharju J 2007 Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. Journal of Biological Chemistry 282 4524-4532. (doi:10.1074/jbc.M610415200)
21. Koppenol WH, Bounds PL & Dang CV 2011 Otto Warburg's contributions to current concepts of cancer metabolism. Nature Reviews Cancer 11 325-337. (doi:10.1038/nrc3038)
22. Letouzé E, Martinelli C, Loriot C, Burnichon N, Abermil N, Ottolenghi C, Janin M, Menara M, Nguyen AT, Benit P et al. 2013 SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer 23 739-752. (doi:10.1016/j.ccr.2013.04.018)
23. Martiniova L, Lai EW, Elkahloun AG, Abu-Asab M, Wickremasinghe A, Solis DC, Perera SM, Huynh TT, Lubensky IA, Tischler AS et al. 2009 Characterization of an animal model of aggressive metastatic pheochromocytoma linked to a specific gene signature. Clinical & Experimental Metastasis 26 239-250. (doi:10.1007/s10585-009-9236-0)
24. Martucci VL & Pacak K 2014 Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment. Current Problems in Cancer 38 7-41. (doi:10.1016/j.currproblcancer.2014.01.001)
25. Morin A, Letouzé E, Gimenez-Roqueplo AP & Favier J 2014 Oncometabolites-driven tumorigenesis: from genetics to targeted therapy. International Journal of Cancer. Journal International du Cancer 135 2237-2248. (doi:10.1002/ijc.29080)
26. Pollard PJ, Brière JJ, Alam NA, Barwell J, Barclay E, Wortham NC, Hunt T, Mitchell M, Olpin S, Moat SJ et al. 2005 Accumulation of Krebs cycle intermediates and over-expression of HIF1a in tumours which result from germline FH and SDH mutations. Human Molecular Genetics 14 2231-2239. (doi:10.1093/hmg/ddi227)
27. Powers JF, Evinger MJ, Tsokas P, Bedri S, Alroy J, Shahsavari M & Tiscler AS 2000 Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice. Cell and Tissue Research 302 309-320. (doi:10.1007/s004410000290)
28. Quail DF & Joyce JA 2013 Microenvironmental regulation of tumor progression and metastasis. Nature Medicine 19 1423-1437. (doi:10.1038/nm.3394)
29. Rapizzi E, Ercolino T, Canu L, Giaché V, FrancalanciM, Pratesi C, Valeri A & Mannelli M 2012 Mitochondrial function and content in pheochromocytoma/paraganglioma of succinate dehydrogenase mutation carriers. Endocrine-Related Cancer 19 261-269. (doi:10.1530/ERC-11-0263)
30. Rapizzi E, Ercolino T, Fucci R, Zampetti B, Felici R, Guasti D, Morandi A, Giannoni E, Giaché V, Bani D et al. 2014 Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation. Hormones & Cancer 5 174-184. (doi:10.1007/s12672-014-0172-3)
31. Richter S, Qin N, Pacak K & Eisenhofer G 2013 Role of hypoxia and HIF2a in development of the sympathoadrenal cell lineage and chromaffin cell tumors with distinct catecholamine phenotypic features. Advances in Pharmacology 68 285-317. (doi:10.1016/B978-0-12-411512-5.00014-2)
32. Richter S, Peitzsch M, Rapizzi E, Lenders JW, Qin N, de Cubas AA, Schiavi F, Rao JU, Beuschlein F, Quinkler M et al. 2014 Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency. Journal of Clinical Endocrinology and Metabolism 99 3903-3911. (doi:10.1210/jc.2014-2151)
33. Santi A, Caselli A, Paoli P, Corti D, Camici G, Pieraccini G, Taddei ML, Serni S, Chiarugi P & Cirri P 2013 The effects of CA IX catalysis products within tumor microenvironment. Cell Communication and Signaling 11 81. (doi:10.1186/1478-811X-11-81)
34. Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB & Gottlieb E 2005 Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-a prolyl hydroxylase. Cancer Cell 7 77-85. (doi:10.1016/j.ccr.2004.11.022)
35. Semenza GL 2013 HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. Journal of Clinical Investigation 123 3664-3671. (doi:10.1172/JCI67230)
36. Sounni NE & Noel A 2013 Targeting the tumor microenvironment for cancer therapy. Clinical Chemistry 59 85-93. (doi:10.1373/clinchem. 2012.185363)
37. Taddei ML, Giannoni E, Comito G & Chiarugi P 2013 Microenvironment and tumor cell plasticity: an easy way out. Cancer Letters 341 80-96. (doi:10.1016/j.canlet.2013.01.042)
38. Takahashi Y, Sipp D & Enomoto H 2013 Tissue interactions in neural crest cell development and disease. Science 341 860-863. (doi:10.1126/science.1230717)
39. Vander Heiden MG, Cantley LC & Thompson CB 2009 Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324 1029-1033. (doi:10.1126/science.1160809)
40. Zhang J & Liu J 2012 Tumor stroma as targets for cancer therapy. Pharmacology & Therapeutics 137 200-215. (doi:10.1016/j.pharmthera. 2012.10.003)